ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

198 hedge funds and large institutions have $4.22B invested in Alnylam Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 36 closing their positions.

Holders
198
Holders Change
-12
Holders Change %
-5.71%
% of All Funds
4.94%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
29
Increased
63
Reduced
72
Closed
36
Calls
$45.9M
Puts
$43.4M
Net Calls
+$2.52M
Net Calls Change
+$5.39M

Top Buyers

1
BlackRock
1
BlackRock
New York
$243M
2
PA
2
Perceptive Advisors
New York
$56.6M
3
RFS
3
Rockefeller Financial Services
New York
$25.9M
4
Goldman Sachs
4
Goldman Sachs
New York
$70.9M
5
RI
5
RTW Investments
New York
$56M

Top Sellers

1
Legal & General Group
1
Legal & General Group
United Kingdom
$1.27M
2
Millennium Management
2
Millennium Management
New York
$596K
3
AG
3
Artal Group
Luxembourg
$15.4M
4
State Street
4
State Street
Massachusetts
$111M
5
TCM
5
TimesSquare Capital Management
New York
$2.05M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$662M 12,907,883 +35,803 +0.3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$617M 12,041,179 +31,208 +0.3%
Dodge & Cox
3
Dodge & Cox
California
$482M 9,399,245 +194,295 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$290M 5,660,213 +200,890 +4%
BlackRock
5
BlackRock
New York
$243M 4,746,234 +4,732,617 +34,755%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$214M 4,167,969 +4,255 +0.1%
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$171M 3,334,511 +16,489 +0.5%
State Street
8
State Street
Massachusetts
$111M 2,166,232 -195,766 -8%
SPC
9
Slate Path Capital
New York
$103M 2,000,000 – –
UBS AM
10
UBS AM
Illinois
$88.7M 1,731,081 +63,655 +4%
BRC
11
Blue Ridge Capital
New York
$81.5M 1,590,000 +270,000 +20%
Goldman Sachs
12
Goldman Sachs
New York
$70.9M 1,383,994 +469,557 +51%
BB
13
BB Biotech
Switzerland
$63.6M 1,241,338 +50,000 +4%
GGHC
14
Gilder Gagnon Howe & Co
New York
$61.8M 1,206,049 -24,745 -2%
PA
15
Perceptive Advisors
New York
$56.6M 1,103,475 +985,000 +831%
RI
16
RTW Investments
New York
$56M 1,092,516 +303,308 +38%
BM
17
Bridger Management
New York
$37.3M 727,091 +8,476 +1%
Morgan Stanley
18
Morgan Stanley
New York
$36M 701,736 -110,448 -14%
1WCM
19
12 West Capital Management
New York
$35.9M 700,000 – –
First Trust Advisors
20
First Trust Advisors
Illinois
$35.6M 694,184 -44,224 -6%
JHIU
21
Janus Henderson Investors US
Colorado
$33.3M 649,399 +131,969 +26%
Norges Bank
22
Norges Bank
Norway
$33M 644,415 -20,248 -3%
ACH
23
ArrowMark Colorado Holdings
Colorado
$31.1M 606,143 -86,593 -13%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$29.6M 576,797 +42,781 +8%
PAMU
25
Pictet Asset Management (UK)
United Kingdom
$28.9M 563,771 +236,379 +72%
1
2 3 4 5